Publicaciones en colaboración con investigadores/as de Instituto Aragonés de Ciencias de la Salud (14)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  3. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

2022

  1. Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts

    Frontiers in Medicine, Vol. 9

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2020

  1. Efficacy and safety of the combination of pravastatin and sorafenib for the treatment of advanced hepatocellular carcinoma (Estahep clinical trial)

    Cancers, Vol. 12, Núm. 7, pp. 1-14

2018

  1. Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome level

    Cancer Medicine, Vol. 7, Núm. 10, pp. 5057-5065

  2. The dietary antioxidant piceatannol inhibits adipogenesis of human adipose mesenchymal stem cells and limits glucose transport and lipogenic activities in adipocytes

    International Journal of Molecular Sciences, Vol. 19, Núm. 7

2017

  1. Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype

    Oncotarget, Vol. 8, Núm. 22, pp. 35848-35862

2016

  1. Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects

    Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 567-582

2015

  1. Peptic ulcer bleeding risk. the role of helicobacter pylori infection in NSAID/low-dose aspirin users

    American Journal of Gastroenterology, Vol. 110, Núm. 5, pp. 684-689

2011

  1. The changing face of hospitalisation due to gastrointestinal bleeding and perforation

    Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 585-591

2009

  1. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice

    American Journal of Gastroenterology, Vol. 104, Núm. 7, pp. 1633-1641

2007

  1. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: A nationwide multicenter study in Spain

    American Journal of Gastroenterology, Vol. 102, Núm. 9, pp. 1878-1892